New Medications: Staying Current in Psychopharmacology Treatments for Mental Health Disorders
Original Recording Date :
Length: 6 hours
This workshop is for new, as well as experienced, staff who need current information about new medications being prescribed for adults and children with depression, anxiety, bipolar disorder, and schizophrenia. Whether working with a client who has already been prescribed a medication or advocating for someone who needs a medication or a medication change, understanding the latest developments in psychopharmacology is essential. The use of newer medications and new information about clinical standards will be discussed. Marketed medications and investigational compounds with promise will be explored. Content will include the use and main effects of current medication protocols in treatment of mental health disorders as well as the latest research contributing to the clinical application of these medications.
Rosenblat, J.D., Simon, G.E., Sachs, G.S., Deetz, I., Doederlein, A., DePeralta, D., Mischka Dean, M., McIntyre, R.S., (2019). Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. Journal of Affective Disorders. 243: 116-120.
Buttar, K., Trigoboff, E., Grace, J.J., (2020). Neuroleptic Malignant Syndrome: Can Be an Unrecognized Chronic Fatal Disease. Innovations in Neuroscience. 17:26-28.
Montejo A.L., Prieto N., de Alarcón R., Casado-Espada N., de la Iglesia J., Montejo L. (2019) Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach. Journal of Clinical Medicine 8(10):1640.
Target Audience: social workers, mental health practitioners, creative arts therapists, marriage and facility therapists, psychologists, addiction professionals, case managers, nurses, and other interested individuals.Customer Service
We are happy to respond to any concerns or questions you may have. Please contact us at by email at email@example.com or by phone at 716-829-5841.
ADA Accommodations: If you require any support for your ADA needs in the United States, please contact us by email at least 3 weeks prior to the event by email at firstname.lastname@example.org or by phone at 716-829-5841.
Dr. Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN is a Clinical Nurse Specialist in private psychotherapy practice in Western New York. She is an Expert Witness and a national and international speaker and consultant on a wide variety of clinical, research, legal and professional topics. Dr. Trigoboff earned her Doctorate in Nursing Science (DNS) in psychiatric nursing from the State University of New York (SUNY) at Buffalo. She is Board Certified in 4 areas, has written chapters in 14 textbooks, as well as publishing dozens of articles in peer reviewed journals. Dr. Trigoboff is also a volunteer faculty for the SUNY at Buffalo School of Medicine, Department of Psychiatry and the School of Pharmacy & Pharmaceutical Sciences.